Heparin has the potential to reduce cTnI concentration by about 20% at a dosage of 90 U/mL due to binding interactions that lower immunoreactivity; meanwhile, the decrease in cTnT levels is attributed to interactions between negatively charged glycosaminoglycan and basic amino acid residues.